Avacta Group (AVCT)

 

Latest News

ShareSoc Growth Company Seminar

RNS Number: 9152G Avacta Group PLC 05 June 2017 5 June 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta to Present at ShareSoc Growth Company Seminar Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, is pleased to announce that its Chief Executive, Alastair Smith, will be presenting...

Issue of Equity

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

2 Biotech's Licence Affimers for Research Use

RNS Number: 7379F Avacta Group PLC 22 May 2017 22 May 2017 Avacta Group plc ("Avacta" or "the Group" or "the Company") Two US biotech companies licence Affimer reagents for research use Exclusive licence deals follow successful custom Affimer evaluations Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagen...

Avacta to be granted patent in China

Avacta Group has announced that the principal patent protecting the Affimer technology had been accepted for grant in C...

All News

DateHeadlineSource
05-06-17ShareSoc Growth Company SeminarRNS
01-06-17Issue of EquityRNS
22-05-172 Biotech's Licence Affimers for Research UseRNS
10-05-17Avacta to be granted patent in China StockMarketWire
08-05-17Moderna releases Phase I trial data for mRNA technologyStockMarketWire
08-05-17Hardman Research: De-risking Moderna's partnershipRNS
05-05-17Avacta CEO to present at Hardman forum StockMarketWire
05-05-17Presenting at the Hardman Private Investor ForumRNS
02-05-17Avacta to Present at BioTrinity 2017RNS
24-04-17Avacta agrees exclusive deal with global diagnostics firm StockMarketWire
24-04-17Diagnostics firm take rights to several AffimersRNS
19-04-17Avacta to present at Shares Spotlight EveningStockMarketWire
19-04-17Avacta to Present at the Shares Spotlight EveningRNS
12-04-17Hardman Research: Another important box tickedRNS
06-04-17Holding(s) in CompanyRNS
06-04-17Holding(s) in CompanyRNS
06-04-17Director/PDMR ShareholdingRNS
05-04-17Avacta Plc to present at the Shares Spotlight Evening in London on 26 April 2017StockMarketWire
03-04-17Avacta revenues rise StockMarketWire
03-04-17Results of Immunogenicity Study with Human SamplesRNS
03-04-17Interim Results for the Period Ended 31 Jan 2017RNS
31-03-17Avacta Presents at Investor Evening Hosted by TPIRNS
31-03-17London Growth and Innovation Forum PresentationRNS
22-03-17Avacta CEO to present at UK Investor ShowStockMarketWire
22-03-17Avacta to present at the UK Investor ShowRNS
21-03-17Hardman Research: Low response would be positive!RNS
30-01-17Director/PDMR ShareholdingRNS
20-01-17Result of Annual General MeetingRNS
20-01-17Avacta sees substantial progress StockMarketWire
20-01-17Trading UpdateRNS
11-01-17Avacta CEO to present at London forum StockMarketWire
11-01-17Presenting at London Growth and Innovation ForumRNS
06-01-17Avacta Plc to present at the Growth and Innovation Forum 2017 in London on 31 January 2017StockMarketWire
05-01-17Director Dealing and Issue of EquityRNS
20-12-16Director/PDMR ShareholdingRNS
16-12-16Holding(s) in CompanyRNS
01-12-16Notice of AGM, Accounts and Directorate ChangeRNS
23-11-16Avacta to present positive Affimer dataStockMarketWire
23-11-16Technical Update: Affinity SeparationRNS
07-11-16Cancer expert joins Avacta scientific advisory board StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory